04/06/2015 - 4:08pm

Public health exchange enrollees fill more prescriptions, but also opt more often for generics or 90-day fills, than their commercial plan counterparts. 

 

04/02/2015 - 10:19am

Alere's i Strep A test received marketing clearance from the Food and Drug Administration on Thursday. 

04/02/2015 - 7:52am

Sam's Club on Thursday sweetened the pot for its Plus and Business Plus members with an offering of five generic prescriptions without charge in most states. 

04/01/2015 - 11:47am

Dr. Reddy's Laboratories on Wednesday acquired UCB's portfolio of dermatology, respiratory and pediatric products. 

04/01/2015 - 10:54am

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

03/31/2015 - 3:57pm

The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.

03/31/2015 - 10:39am

Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed. 

03/31/2015 - 9:29am

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

03/30/2015 - 10:50am

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.